View of Effects of Empagliflozin/Linagliptin on Oxidative Stress Markers in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Randomized, Open-Label, Controlled Trial

Return to Article Details Effects of Empagliflozin/Linagliptin on Oxidative Stress Markers in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Randomized, Open-Label, Controlled Trial Download Download PDF